Qkine, a Cambridge, England, UK-based specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, closed a further £550K in funding.
The round was led by Cambridge Enterprise and five angel investors – all of whom followed initial seed investments made in April 2018. Joining the original investors is biotech entrepreneur and founder member of the Cambridge Angels, Dr Andy Richards CBE.
The company intends to use the funds to establish its UK manufacturing base at Cambridge Science Park, accelerate the expansion of its research team and further develop its active R&D pipeline.
A University of Cambridge spin-out, Qkine is a specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications.
The company uses proprietary technologies and protein engineering techniques to produce high purity growth factors and cytokines to solve scientific challenges such as structural heterogeneity, poor stability and solubility and spurious interactions with other biomolecules, and provide reliable tools for research and bio-manufacturing.